The People's Republic of China (PRC) possesses a significant nuclear arsenal that is a key component of its national defense strategy. The development of China's nuclear weapons program began in the late 1940s, and the country successfully conducted its first nuclear test on October 16, 1964, making China the fifth nation to possess nuclear weapons.
Nuclear missiles of the People's Republic of China (PRC) are part of China's strategic military capabilities, designed to serve as a deterrent against nuclear and conventional threats. China has developed a diverse range of nuclear delivery systems over the years, which include land-based intercontinental ballistic missiles (ICBMs), submarine-launched ballistic missiles (SLBMs), and strategic bombers equipped for nuclear roles.
The JL-1, also known as the CSS-N-3, is a submarine-launched ballistic missile (SLBM) developed by China. It was the first ballistic missile designed for deployment on Chinese submarines and was introduced in the 1980s. The JL-1 is specifically intended for use with China's Type 092 submarine (also known as the Xia-class), which was China's first attempt at developing a nuclear-powered submarine capable of carrying ballistic missiles.
The JL-2 is a type of submarine-launched ballistic missile (SLBM) developed by China. It is designed to be deployed on the country's Jin-class submarines, also known as Type 094 submarines. The JL-2 missile is capable of carrying both conventional and nuclear warheads and has an estimated range of around 7,000 to 8,000 kilometers, allowing it to target locations well outside of China.
The JL-3, also known as the DF-41 (Dong Feng-41), is a Chinese intercontinental ballistic missile (ICBM) developed by China. It is part of China’s strategic nuclear deterrent forces and is designed to deliver multiple nuclear warheads over long distances, with an estimated range of about 12,000 kilometers (approximately 7,500 miles). This missile is capable of reaching targets in the continental United States.
Articles by others on the same topic
There are currently no matching articles.